World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
60
Citations
26158
World Ranking
11672
National Ranking
832

Heike L. Pahl publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Heike L. Pahl sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 181 publications — 42nd percentile

42% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Heike L. Pahl D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Heike L. Pahl sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 60 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Heike L. Pahl is affiliated with the University of Freiburg in Germany and has contributed extensively to the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their research focuses primarily on hematology, molecular biology, genetics, oncology, and immunology, with a notable emphasis on myeloproliferative neoplasms and related blood disorders.

The scientist's work spans a range of main topics, including:

  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Chronic Myeloid Leukemia Treatments
  • Kruppel-like factors research
  • Acute Myeloid Leukemia Research
  • Eosinophilic Disorders and Syndromes
  • Epigenetics and DNA Methylation
  • Cytokine Signaling Pathways and Interactions

Heike L. Pahl has published research in various prominent scientific journals. Frequent publication venues include:

  • Blood
  • Leukemia
  • Journal of Clinical Investigation
  • Cancer Research
  • Cancers

Recent significant papers authored or co-authored by Pahl reflect active contributions to research on inflammation, leukemogenesis, immune response, and disease severity in blood cancers. Notable publications include:

  • "Malignant JAK-signaling: at the interface of inflammation and malignant transformation" (2025, Leukemia)
  • "Kidney Dysfunction Is Associated with Thrombosis and Disease Severity in Myeloproliferative Neoplasms: Implications from the German Study Group for MPN Bioregistry" (2021, Cancers)
  • "GPRC5C drives branched-chain amino acid metabolism in leukemogenesis" (2023, Blood Advances)
  • "Oncogene-induced TIM-3 ligand expression dictates susceptibility to anti-TIM-3 therapy in mice" (2024, Journal of Clinical Investigation)
  • "Oncogenic Calreticulin Induces Immune Escape by Stimulating TGFβ Expression and Regulatory T-cell Expansion in the Bone Marrow Microenvironment" (2024, Cancer Research)

Collaborative work is a notable aspect of Pahl's research, with frequent co-authors including:

  • Hans Felix Staehle
  • Steffen Koschmieder
  • Albert Gründer
  • Robert Zeiser
  • Florian H. Heidel

Through their contributions, Heike L. Pahl has established a research profile centered on deeper understanding and treatment strategies for blood cancers and related hematologic disorders. Their focus on molecular mechanisms, genetic factors, and immune system interactions continues to align with contemporary investigations in hematology and oncology.

Best Publications

  • Activators and target genes of Rel/NF-kappaB transcription factors.

    Heike L Pahl

  • Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli.

    E. B.-M. Traenckner;H. L. Pahl;T. Henkel;K. N. Schmidt

  • MyD88, an adapter protein involved in interleukin-1 signaling.

    Kimberly Burns;Fabio Martinon;Christoph Esslinger;Heike Pahl

  • Tyrosine Phosphorylation of IκB-α Activates NF-κB without Proteolytic Degradation of IκB-α

    Véronique Imbert;Rudolf A Rupec;Antonia Livolsi;Heike L Pahl

  • The anti-inflammatory sesquiterpene lactone helenalin inhibits the transcription factor NF-kappaB by directly targeting p65

    G Lyss;A Knorre;T J Schmidt;H L Pahl

  • A novel signal transduction pathway from the endoplasmic reticulum to the nucleus is mediated by transcription factor NF-kappa B.

    H.L. Pahl;P.A. Baeuerle

  • Cysteine 38 in p65/NF-κB Plays a Crucial Role in DNA Binding Inhibition by Sesquiterpene Lactones

    Alfonso J. Garcı́a-Piñeres;Vı́ctor Castro;Gerardo Mora;Thomas J. Schmidt

  • The ER-overload response: activation of NF-κB

    Heike L. Pahl;Patrick A. Baeuerle

  • Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs

    Robyn M. Emanuel;Amylou C. Dueck;Holly L. Geyer;Jean Jacques Kiladjian

  • JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms.

    Amy V Jones;Andrew Chase;Richard T Silver;David Oscier

  • Regulation of the transcription factors NF-κB and AP-1 by redox changes

    Markus Meyer;Heike L. Pahl;Patrick A. Baeuerle

  • The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-kappaB.

    H. L. Pahl;B. Krauss;K. Schulze-Osthoff;T. Decker

  • The proto-oncogene PU.1 regulates expression of the myeloid-specific CD11b promoter.

    H. L. Pahl;R. J. Scheibe;Dong-Er Zhang;Hui-Min Chen

  • Inhibition of transcription factor NF-κB by sesquiterpene lactones: a proposed molecular mechanism of action

    Peter Rüngeler;Victor Castro;Gerardo Mora;Nezhun Gören

  • Oxygen and the control of gene expression

    Heike L. Pahl;Patrick A. Baeuerle

  • Helicobacter pylori Activates Mitogen-activated Protein Kinase Cascades and Induces Expression of the Proto-oncogenes c-fos and c-jun

    Tobias Meyer-ter-Vehn;Antonello Covacci;Manfred Kist;Heike L. Pahl

  • Helenalin, an anti-inflammatory sesquiterpene lactone from Arnica, selectively inhibits transcription factor NF-kappaB

    Guido Lyss;Thomas J. Schmidt;Irmgard Merfort;Heike L. Pahl

  • Activation of NF‐κB by ER stress requires both Ca2+ and reactive oxygen intermediates as messengers

    Heike L. Pahl;Patrick A. Baeuerle

  • The Sp1 transcription factor binds the CD11b promoter specifically in myeloid cells in vivo and is essential for myeloid-specific promoter activity.

    Hui-Min Chen;H. L. Pahl;R. J. Scheibe;Dong-Er Zhang

  • Cloning of PRV-1, a novel member of the uPAR receptor superfamily, which is overexpressed in polycythemia rubra vera.

    Snežana Temerinac;Steffen Klippel;Elisabeth Strunck;Sabine Röder

Frequent Co-Authors

Alessandro Rambaldi
Alessandro Rambaldi University of Milan
Andreas Reiter
Andreas Reiter Heidelberg University
Amylou C. Dueck
Amylou C. Dueck Mayo Clinic
Francisco Cervantes
Francisco Cervantes University of Barcelona
Harry C. Schouten
Harry C. Schouten Maastricht University
Ruben A. Mesa
Ruben A. Mesa The University of Texas Health Science Center at San Antonio
Francesco Passamonti
Francesco Passamonti University of Milan
Alessandro M. Vannucchi
Alessandro M. Vannucchi University of Florence
Claire N. Harrison
Claire N. Harrison Guy's and St Thomas' NHS Foundation Trust
Tiziano Barbui
Tiziano Barbui FROM-Fondazione per la Ricerca Ospedale di Bergamo

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online education can open new doors for students interested in Biology and Biochemistry. Many choose to start with online medical assistant programs fafsa approved to gain experience in healthcare settings. These programs offer flexibility and valuable foundational skills while keeping financial options accessible through federal aid.

For those looking to advance their clinical roles, pathways like cma to lpn programs are designed to bridge the gap between a Certified Medical Assistant (CMA) and Licensed Practical Nurse (LPN). This step can greatly expand career opportunities and responsibilities in the medical field.

Students seeking a faster route to a science degree may be drawn to an accelerated biology degree. These intensive online options allow learners to complete coursework at a quicker pace, perfect for motivated individuals eager to enter research or advanced studies sooner.

Finally, those interested in nursing may consider an asn program online. This pathway prepares students for entry-level nursing positions and can serve as a launchpad for further specialization or degree advancement in the healthcare sector.

Best Scientists Citing Heike L. Pahl

Trending Scientists